Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Autoregulation Assessment During Liver Transplantation
This is an update of a completed clinical trial evaluating autoregulation during liver transplantation.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation [Phase 4]
This Phase 4 study assesses the pharmacokinetics, safety, and efficacy of Advagraf (tacrolimus extended-release) versus Prograf (tacrolimus)…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients [Phase 2]
Phase 2 trial update on immunosuppression withdrawal in stable pediatric liver transplant recipients; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients [Phase 4]
Phase 4 trial update on the efficacy and safety of cyclosporine microemulsion in diabetic adult stable liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression. [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase I/II study examining extracorporeal photopheresis in liver transplant recipient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to Outcomes
A clinical trial update from Ain Shams University examines how human leukocyte antigen matching influences outcomes after liver transplantat…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
The clinical trial evaluating an endotracheal cardiac output monitor (ECOM) in liver transplantation was terminated, ending enrollment and a…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver [Phase 1, Phase 2]
Phase 1/2 trial investigating adefovir plus vaccination in liver transplant recipients without Hepatitis B who are core antibody positive; s…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus [NA]
A completed clinical trial evaluated tacrolimus flushing for use during liver transplantation to mitigate ischemia-reperfusion injury and ea…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients
This completed trial evaluated switching liver transplant recipients from sirolimus to everolimus as maintenance immunosuppression.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy [Phase 4]
Phase 4 trial exploring switching stable transplant recipients from mycophenolate mofetil to enteric-coated mycophenolate sodium due to gast…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients [NA]
This prospective study in liver transplant recipients examines converting immunosuppression from CellCept (mycophenolate mofetil) to Myforti…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors [NA]
A completed clinical trial evaluated whether oral and sublingual tacrolimus dosing provide equivalent exposure. The study focused on patient…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Phase 2, Phase 3]
A Phase 2/3 trial comparing zoledronic acid to alendronate for prevention of bone loss after organ transplantation has completed with result…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Improving Medication-taking After Liver Transplant [Phase 1]
Phase 1 trial update from Icahn School of Medicine at Mount Sinai evaluating strategies to improve tacrolimus adherence after liver transpla…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant
This clinical trial update notes termination of the study evaluating a cytokine kinetics test to assess tolerance in kidney and liver transp…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids [Phase 2]
Phase 2 study assessing safety, tolerability, and pharmacokinetics of oral mycophenolate mofetil (CellCept) in pediatric liver transplant re…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant [Phase 3]
Phase 3 trial evaluating long-term safety and efficacy of prolonged-release tacrolimus (FK506E-MR4) in transplant recipients when used with …
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation [Phase 3]
A Phase 3 trial comparing the efficacy and safety of FK506MR (tacrolimus modified-release) versus Prograf (tacrolimus) in liver transplant p…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients [Phase 3]
A Phase 3 trial comparing FK506MR with Prograf in stable liver transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients [Phase 4]
A Phase 4 study comparing Tacrolimus regimens Prograf plus Mycophenolate mofetil versus Advagraf plus Mycophenolate mofetil in liver transpl…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients [Phase 4]
A single-center Phase 4 pilot study evaluated whether liver transplant recipients could safely discontinue corticosteroids.
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
This clinical trial update reports cefepime pharmacokinetics in liver transplant recipients in an intensive care unit, reflecting dosing con…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation [NA]
This clinical trial update compares propofol versus dexmedetomidine for preventing sevoflurane-related agitation in recipients of living-don…
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients [Phase 2]
Phase 2 pharmacokinetic data for LCP-Tacro were evaluated in stable liver transplant patients. The study was sponsored by Veloxis Pharmaceut…